Company profile
GAMA Healthcare
Founded by two medical doctors, GAMA is the preferred choice for infection prevention professionals worldwide. Our innovative products, verified science and award-winning aftersales support provide the best tools to protect patients from infection.
Updated 06 Jun 2026 16:52
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Feb 2019 to 31 Aug 2022
The use of antimicrobial treatments in agriculture is vital in protecting animal health and aiding the production of safe and nutritious food. However, previous overuse, and continued use of antibiotics in agriculture has been attributed to the rise in multi-drug resistance (MDR) bacteria, which can lead to ill-health and even death in humans if infected....
1 Feb 2019 to 28 Feb 2022
To reduce microbial contamination on surfaces and infection by developing novel and effective antimicrobial surfaces to reduce patients getting a microbial infection.
1 Apr 2016 to 31 Mar 2017
Products derived from this project will enhance patient safety and aim to reduce the incidence of small surgical site infections and catheter related infections. Dealing with biofilm protected organisms is seen as an important step in improving clinical outcomes in a number of medical cases. Novel formulations proposed in this project potentially offer a ...
1 Apr 2016 to 31 Mar 2019
To acquire new knowledge and new technologies that will enable Gama Healthcare to formulate and market new products that are effective against viruscidal and tuberculocidal infections
1 May 2015 to 31 Oct 2016
To acquire new knowledge and technologies which will enable development of existing products and create new products to meet new market and new customer requirements.
1 Jun 2012 to 30 Jun 2014
To enhance products, create data demonstrating their efficacy and lay the foundation for an R&D facility to enable products to be developed independently.
